Fiocruz Completes National Production of Dolutegravir, Bolstering Brazil's HIV Treatment Autonomy
Fiocruz completes technology transfer enabling Brazil to produce dolutegravir locally, securing HIV treatment access for over 770,000 patients.
Fiocruz completes technology transfer enabling Brazil to produce dolutegravir locally, securing HIV treatment access for over 770,000 patients.